Difference between revisions of "Team:MIT"

Line 37: Line 37:
 
     </a>
 
     </a>
 
   </li>
 
   </li>
<br></ul><br>
+
<br></ul>
<center><h2>We've accomplished a lot in successfully creating new, hormone-inducible mammalian promoters, characterizing a miRNA sensing platform in TERT-immortalized human endometrial stromal cells (tHESC) culture under varying estrogen conditions, and testing the functionality of a serine integrase (TP901) in a mammalian line as a biological latch, and we've spent a long time visualizing how these tools could be used in the long term to help patients with endometriosis.</h2></center>
+
<center><h2>We've successfully created new, hormone-inducible mammalian promoters, characterized a miRNA sensing platform in TERT-immortalized human endometrial stromal cells (tHESC) culture under varying estrogen conditions, and tested the functionality of a serine integrase (TP901) in a mammalian line as a biological latch.<br><br>We've spent a long time visualizing how these tools could be used in the long term to help patients with endometriosis.</h2></center><br><br>
 
<ul class="img-home">
 
<ul class="img-home">
 
<li>   
 
<li>   

Revision as of 20:06, 16 October 2016


This diagnostic process can be expedited by using the following synthetic biological tools to sense molecular markers in endometrial biopsy samples.


We've successfully created new, hormone-inducible mammalian promoters, characterized a miRNA sensing platform in TERT-immortalized human endometrial stromal cells (tHESC) culture under varying estrogen conditions, and tested the functionality of a serine integrase (TP901) in a mammalian line as a biological latch.

We've spent a long time visualizing how these tools could be used in the long term to help patients with endometriosis.